Risperdal Study Allegedly Manipulated to Understate Risks

After pediatrician Dr. Denis Daneman co-authored a study with Janssen Pharmaceuticals employees outlining the risks associated with anti-psychotic drug Risperdal, the study’s results were purportedly manipulated to understate the drug’s risks. Misrepresentations of the study—which found no correlation between long-term use of Risperdal and certain side-effects such as gynecomastia, or breast growth in boys—were highlighted in recent lawsuits against Janssen, Risperdal’s manufacturer.

Real Time Analytics